Researchers at the Mayo Clinic in Florida have developed a new strategy that can improve the treatment of ductal adenocarcinoma of pancreatic cancer, which accounts for more than 95 percent of pancreatic cancer cases. It is a fast-growing, often deadly form of cancer, resistant to traditional chemotherapy.